OPA Bulletin

  • News for the Week of April 14, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Third-party Payor Tools on Standard Refill Policies and COVID-19 Policy Exceptions
    • OPA in the News: Pharmacists are the other frontline health workers (healthing.ca) April 14, 2020, Lisa Machado
    • An Open Letter to the Patients of Ontario Pharmacists
    • Pharmacists' Matters - Episode 2
    • Guidance on Use of PPE for ANY Regulated Healthcare Professionals in Hospitals/LTCs/Retirement Homes (Directive #5)
    • From the College: Guidance on the Controlled Drugs and Substances Act (CDSA) Subsection 56(1) Exemption
    • Information on Non-insured Health Benefits (NIHB)
    • Province Developing New Health Data Platform to Help Defeat COVID-19
    • Ontario Significantly Expanding COVID-19 Testing
    • Pharmacy5in5 Quiz: How to Provide Video Consults During the COVID-19 Pandemic
    • ICYMI: Pharmacist's Letter Canada: Coronavirus (COVID-19) Resource Hub

    • Ask the Practice Support Network
    • ICYMI: New OPA Partnership to Support COVID-19 Staffing

    • New Pandemic Tips from OPA Course Instructors

    • Are You Financially Exposed Due to Inadequate Store Insurance Coverage?

    • DDD Notice No. 20069 Posted April 14, 2020 Prescription Forgery Alert
    • DDD Notice No. 20068 Posted April 14, 2020 Prescription Forgery Alert

    • Fraudulent and unauthorized N95 respirators may not protect consumers against COVID-19

  • News for the Week of April 7, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • A Thank You to Pharmacy Professionals on National Caregiver and World Health Day
    • Return-to-Work Visual for Pharmacy Professionals During COVID-19
    • New OPA Partnership to Support COVID-19 Staffing
    • Revised Process for Ordering PPE
    • Ontario Government Launches Healthcare Workforce Matching Portal
    • Council of Chief Medical Officers of Health Guidance on Use of Non-Medical Masks by the Public
    • Deputy Minister Notice on Re-Use of PPE
    • Importance of Naloxone During Pandemic
    • Financial Assistance for Pharmacists During COVID-19
    • Pharmacist's Letter Canada: Coronavirus (COVID-19) Resource Hub
    • A Video Message from OPA EVP and Chief Pharmacy Officer, Allan Malek, to Ontario Patients on 30-day Limits

    • Ask the Customer Experience and Administration Team
    • Deadline Extended for OPA Awards Nomination

    • New Pandemic Tips from OPA Course Instructors

    • Returning to Practice to Support Pharmacy During the COVID-19 Pandemic
    • OPA Store Insurance Renewal 2020 - 2021

    • DDD Notice No. 20067 posted April 7, 2020 ODB FORMULARY – EDITION NO. 43, Summary of Changes – April 7, 2020
    • DDD Notice No. 20066 posted April 7, 2020 Executive Officer Notice: Regulation Amendments to Private Label Products and Brand Reference Pricing Rules
    • DDD Notice No. 20064 posted April 6, 2020 Prescription Forgery Alert
    • DDD Notice No. 20061 posted April 1, 2020 Notice: Extending Submission Period for Electronic Drug Claim Reversals AND The Ontario Drug Programs Reference Manual, Revision #1
    • DDD Notice No. 20060 posted April 1, 2020 Notice from the Executive Officer: Policy for Methadone Maintenance Treatment Reimbursement under the Ontario Drug Benefit Program

    • Homemade Hand Sanitizers May Present Health Risks

  • News for the Week of March 31, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Updated: Pharmacist's Guide to Pandemic Preparedness
    • Updated: COVID-19 Case Definition
    • New Process for PPE Ordering Coming
    • Emergency Child Care Services for Pharmacy Professionals
    • OPA CEO Video Message to Pharmacy Professionals
    • 30 Days' Supply Recommendation Video Explainer from CPhA
    I• ndustry Webinar: Managing the Challenges of Operating a Health Services Business During COVID-19
    • ICYMI: Pharmacists' Matters Launches Episode #1
    • ICYMI: Ontario’s Action Plan: Responding to COVID-19

    • Ask the Practice Support Network
    • Nominations for OPA Awards Deadline Extended

    • Canadian Diabetes Educator Exam Postponed

    • Business Expense Disability Insurance

    • DDD Notice No. 20058 posted Mar 30, 2020 Notice from the Executive Officer: Proposed Regulatory Amendments on Rules for Determining Brand Reference Prices
    • DDD Notice No. 20057 posted Mar 30, 2020 EO Notice: Proposed amendments to the effective date of changes to allow Private Label Products to be funded under the Ontario Drug Benefit (ODB) Program and Designated as Interchangeable on the ODB Formulary
    • DDD Notice No. 20056 posted March 30, 2020 EO Notice: Funding of Truxima (rituximab) under the Ontario Drug Benefit Program
    • DDD Notice No. 20055 posted March 26, 2020 Notice: COVID-19 Related Drug Prescribing
    • DDD Notice No. 20054 Posted March 25, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies

    • Health Canada Important Safety Information on Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
    • Certain Lots of Taro-Zoledronic acid injection drug, used for osteoporosis and Paget's disease, recalled due to potential presence of particulate matter
    • Stockpiling drugs can lead to local shortages: Canadians urged not to buy more medication than usual during the COVID-19 pandemic
    • Health products that make false or misleading claims to prevent, treat or cure COVID-19
    • Health Product InfoWatch - March 2020

  • News for the Week of March 24, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • A Joint Message to Ontario’s Doctors, Nurses, Nurse Practitioners and Pharmacists on Use of Hydroxychloroquine and Azithromycin
    • Updated: Supplementary FAQs to the Notice of the Executive Officer issued Friday, March 20
    • COVID-19 and Non-Insured Health Benefits Coverage
    • Exemptions for Controlled Substances During COVID-19
    • Protect Your Pharmacist Social Card
    • Pharmacists' Matters Lauches Episode #1

    • Ask the Customer Experience Administration Team
    • GoodLife, OPA affinity partner, stepping up to help members through COVID-19

    • OPA Store Insurance – Understanding Your Coverage During COVID-19

    • DDD Notice No. 20053 posted March 24, 2020 ODB Formulary Edition No. 43, Summary of Changes – March 31, 2020
    • DDD Notice No. 20051 posted March 20, 2020 EO Notice: Ontario Drug Benefit (ODB) Program Changes & Guidance for Dispensers during the COVID-19 Public Health Emergency

    • No scientific evidence that ibuprofen worsens COVID-19 symptoms
    • Expedited access to disinfectants, hand sanitizers and personal protective equipment to help limit the spread of COVID-19, as well as swabs for testing

  • News for the Week of March 17, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA's Pharmacist's Guide to Pandemic Preparedness
    • OPA signage for entrances to pharmacy
    • Updated Guidance for Pharmacies on COVID-19 from the Ministry of Health
    • CPhA: COVID-19 and the responsible allocation of medications to patients
    • Sharing your concerns on personal protective equipment
    • Community pharmacy owners support Ontario patients during COVID-19
    • OPA staff work remotely

    • Methadone, Buprenorphine and the Community
    • FREE Take-Home Naloxone at Community Pharmacies
    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults

    • Ask the Practice Support Network

    • What you need to know when it comes to your benefits

    • DDD Notice No. 20050 posted March 17, 2020 Prescription Forgery Alert
    • DDD Notice No. 20049 posted March 17, 2020 Prescription Forgery Alert
    • DDD Notice No. 20048 posted March 13, 2020 EO Notice: Monitored Drugs List (MDL)

    • Update on the rifampin drug shortage

  • News for the Week of March 10, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Update on COVID-19
    • Pharmacist Awareness Month at Ontario Schools of Pharmacy
    • OPA Thought Leadership Launching During PAM
    • University of Toronto Initiates "I’m Pharmacy” Campaign
    • ICYMI: OPA Celebrates International Women's Day with Launch of Women of Pharmacy Conference Event
    • Board of the Canadian Foundation for Pharmacy Announces New Grant
    • Lung Health Foundation Needs Assessment Survey
    • Humber College Pharmacy Advisory Committee

    • Certified Diabetes Educator (CDE) Preparation Course
    • Identifying Drug Interactions
    • Managing Your Pharmacy: The Business Essentials

    • Ask the Customer Experience and Administration Team

    • Disability Insurance – Q & A

    • DDD Notice No. 20045 Posted March 10, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification

    • Drug Shortage / Supply Health System Alert: Kidrolase

  • News for the Week of March 3, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Uniting as a Profession to Respond to the Needs of Patients During COVID-19
    • Ontario Protecting Children and Youth from Dangers of Vaping
    • Green Shield Canada Brand-Drug Loyalty Card Policy
    • UofT Leslie Dan Faculty of Pharmacy Takes Back the OPA Cup!
    • ICYMI: It's Pharmacist Awareness Month!
    • Complete the Survey on Opioid Use in Cancer-related Pain

    • Opioid Addictions and Substitution Therapy FREE Live Webinar Series - March 11, 2020
    • Certified Diabetes Educator (CDE) Preparation Course *2020 Update*
    • Implementing Smoking Cessation Services in the Pharmacy *2020 Update*

    • Ask the Practice Support Network
    • Nominate a Colleague for an OPA Award!

    • Did You Know Cancer Is the Leading Cause of Death in Canada?

    • DDD Notice No. 20040 posted March 2, 2020 Prescription Forgery Alert
    • DDD Notice No. 20039 posted March 2, 2020 Prescription Forgery Alert
    • DDD Notice No. 20038 posted March 2, 2020 EO Notice: Reconciliation Adjustment Percentages for 2020/21 to Improve the Value of Pharmacy Payments

    • Health Product InfoWatch - February 2020
    • Certain Metformin Diabetes Drugs Recalled Due to the Presence of NDMA

  • News for the Week of February 25, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • The Winter 2020 Issue of Ontario Pharmacist Magazine is here!
    • COVID-19 Resources Available on OPA website
    • Last chance: National Pharmacist Survey on Opioid Prescribing and Dispensing Practices
    • Kick-off this year's Pharmacist Awareness Month with the OPA Cup!
    • Reminder: Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

    • Essential Cannabis Knowledge for Pharmacists Certificate Program
    • How-To: Ontario’s Pharmaceutical Opinion Program
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists

    • Ask the Customer Experience and Administration Team

    • Practising in Ontario and One or Two Other Provinces?

    • DDD Notice No. 20037 posted February 24, 2020 Prescription Forgery Alert
    • DDD Notice No. 20036 posted February 21, 2020 Prescription Forgery Alert
    • DDD Notice No. 20035 posted February 20, 2020 ODB Formulary – Edition No. 43, Summary of Changes – February 2020
    • DDD Notice No. 20034 posted February 19, 2020 Prescription Forgery Alert
    • DDD Notice No. 20033 posted February 19, 2020 Prescription Forgery Alert
    • DDD Notice No. 20032 posted February 19, 2020 Prescription Forgery Alert

  • News for the Week of February 18, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Consultation Submission on Proposed Changes to OCP Council Governance and Fees
    • ICYMI: COVID-19 Guidance Document for Community Pharmacies
    • National Pharmacist Survey on Opioid Prescribing and Dispensing Practices

    • *New* Wearable Technology
    • Paid Consultations - Opportunities and Timesavers
    • Identifying Drug Interactions

    • Ask the Practice Support Network

    • Planning to Work in Another Province?

    • DDD Notice No. 20029 posted February 12, 2020 Elimination of Red and White Health Card - Posters for Display

  • News for the Week of February 11, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA's Pre-budget Consultation Submission
    • FIP Guidance Resources for Managing Coronavirus in Pharmacy
    • New Awards to Celebrate Leslie Dan Faculty of Pharmacy Alumni
    • University of Waterloo Survey on Readiness to Assess and Prescribe for Minor Ailments
    • ICYMI: Elimination of Red and White Health Cards
    • 2nd Coalition of Pharmacists Caring for Aging Canadians (CPCAC) Scientific Meeting

    • *Free* Methadone, Buprenorphine and the Community
    • Rational Prescribing: Re-Thinking Medications
    • *Free* Assessment and Management of Patients with Migraine

    • Ask the Customer Experience Administration Team

    • Planning to Retire or Moving to Part B?

    • DDD Notice No. 20027 posted February 10, 2020 Trillium Drug Program - New Online Application Form and Guide
    • DDD Notice No. 20028 posted February 11, 2020 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Dexamethasone, Ranitidine, Tamoxifen February 7, 2020

    • Apotex Inc. Recalls Certain Lots of Diabetes Medication APO-Metformin ER (extended release) 500 mg Tablets

Back to top